|
HS Code |
940908 |
As an accredited Ethyl 6-Bromo-1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Ethyl 6-Bromo-1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Talk to any bench chemist, and chances are, they’ve developed a neck for finding molecules that open doors in synthesis. Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate is exactly that sort of molecule — unassuming on paper, yet quietly powerful in hands that know how to put it to work. This compound delivers more than just a carefully constructed scaffold; it serves as a building block for researchers pushing the boundaries of pharmaceutical science, agrochemistry, and advanced materials.
One detail that stands out is the core itself: pyrrolo[2,3-b]pyridine rings have stepped into the spotlight over the last decade, especially in medicinal chemistry circles. Attaching a bromo group at the 6-position may seem modest, but it gives this molecule a flexible starting point for Suzuki or Buchwald-Hartwig couplings and other cross-coupling reactions chemists often rely on in the hunt for new drug candidates. The ethyl ester at the 2-position makes downstream modifications easier, whether for hydrolysis, amidation, or functional group swaps, so synthetic routes stay open rather than bottlenecked.
Chemists care about modularity and predictability when shopping for fine chemicals. Here, you see both. The addition of bromine provides a reactive handle that lets chemists introduce diversity with relative ease, especially compared to some substituted pyridine derivatives where steric hindrance becomes a real headache. Working with this compound means each batch can adapt to the direction that complex multi-step syntheses demand.
What sets this molecule apart? For starters, its solid-state stability makes weighing and handling more straightforward than with some liquid or hygroscopic intermediates. From a personal standpoint, I’ve lost count of the number of promising reagents that turned into sticky, hard-to-measure messes by the second or third use — a frustration this compound sidesteps cleanly due to its crystalline nature. Reliable, well-defined melting points and solubility in common organic solvents factor heavily when reactions need to scale, or when purification through crystallization is on the table.
As chemists, we know the headaches that arise from trace impurities or reagent instability. Purity here often checks in above 98%, keeping downstream analysis tight and reaction outcomes more predictable. Consistency over time also keeps quality-control managers content, which in turn builds trust with regulatory teams and external partners. To put it plainly, nobody wants to troubleshoot side-products popping up two steps downstream because the initial building block had lingering contaminants. Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate eliminates much of that guesswork.
Medicinal chemists are constantly searching for new molecular shapes to explore biological space. Pyrrolo[2,3-b]pyridines stand out partly because their fused ring topology mimics natural biomolecular scaffolds without being overly rigid. Researchers have noted these skeletons in kinase inhibitors, serotonin receptor modulators, and other bioactive molecules thanks to their balance of aromatic surface area and hydrogen-bonding capacity.
Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate doesn’t show up in finished medicines on the pharmacy shelf. What it does do — and what makes it matter — is show up early in a project’s life, where creative analog design shapes the eventual direction of a drug candidate. Substitution at the 6-position and modification of the ester handle give chemists a playground for exploring SAR, optimising potency, or tuning ADME properties. In biopharma settings where speed and adaptability are prized, starting with a building block designed for future functionalization saves both time and budget.
Think about the movement in drug discovery toward more tractable, efficient synthesis. Introducing a bromo handle helps chemists build libraries by enabling quick diversification through palladium-catalyzed coupling strategies. The efficiency this brings often means fewer overall steps, translating to higher yields, faster lead optimization, and ultimately, better odds of advancing a candidate into animal testing or even clinical trials.
Environmental responsibility is never far from a chemist’s mind these days. Synthetic steps involving organobromides have a mixed reputation, and some in the field raise eyebrows at “legacy” reagents for their potential environmental burden. At the same time, contemporary palladium-catalyzed methods handle aryl bromides more gently and with fewer byproducts. More teams are also designing reuse protocols for catalysts, and some have moved to continuous-flow systems that minimize waste and cut down on hazardous exposures. Working with this compound as a base for more sustainable protocols can give R&D groups a tangible way to demonstrate progress on green chemistry targets while still working within the boundaries of proven, efficient science.
Sometimes, efficiency comes from a molecule’s cooperation with solvents and catalysts. The ethyl ester keeps polarity balanced, so researchers can access both aqueous and organic phases when extracting, purifying, or reacting. This feature also eases pressure on solvent selection, a point often overlooked until late-stage development. Less solvent swapping, milder purification, and compatibility with automation mean fewer headaches — and less room for mistakes with expensive or hazardous materials.
Structure-activity relationships drive most decision-making in medicinal chemistry. Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate stands out because its three key features — the fused ring, the bromine atom, and the ester group — can be used to probe a wide set of pharmacophores. You find this especially helpful during lead generation. It sits in the “sweet spot” where molecular complexity and synthetic tractability meet, letting teams iterate structures with efficiency and speed.
Over the years, chemists have leaned on fused aza-heterocycles like this one to unlock new pathways in kinase inhibitors and CNS-targeted molecules. One practical value comes from the way its planar but non-symmetrical ring system dips into protein grooves and forms key π-stacking or hydrogen-bonding interactions. The position and type of substituent modulate these interactions, so being able to swap out the bromine or convert the ethyl ester to a carboxamide, for example, can make the difference between an active and inactive analog.
Chemistry isn’t short on pyridine starting materials — they fill catalogs and freezers all over the world. What separates Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate from the crowd isn’t just availability, but the combination of electronic and steric factors packed into its structure. Compared with unsubstituted pyridines, its fused ring restricts rotation, creates new vectors for substitution, and enhances π-electron delocalization.
Substituents on standard pyridine rings often create synthetic dead-ends or require harsh conditions for cross-coupling. Here, the fused system lowers the activation barrier for many common transformations. Also, intermediate boiling points minimize evaporation or loss, which can be critical in open or large-scale reaction vessels. These practical details shift the calculus for chemists tasked with delivering multi-gram batches under tight deadlines.
When measured against similar molecules like methyl or propyl esters, the ethyl group offers a compromise: good stability during workup combined with ready removal under mild conditions. That means you can slip it through reaction sequences, adjust as needed on the fly, and transition to carboxylic acids or amides without resorting to aggressive hydrolysis or high-pressure setups.
While most conversation about this molecule happens in the shadow of drug discovery, the same features that appeal to pharmaceutical chemists turn heads in related fields. For instance, agrochemical researchers look for new scaffolds with improved resistance to enzymatic breakdown or environmental degradation. Fused pyridine derivatives like this one can resist standard metabolites, boosting persistence without heavy environmental penalties.
In material science, the search for heterocyclic monomers with uncommon electronic and optical profiles keeps advancing. The bromine atom can act as a “tag” for subsequent coupling to polymers or surface-functionalized nanoparticles, injecting precisely engineered properties into the final material. These tweaks — sometimes minor at the molecular level — unlock improvements in organic electronics, sensors, or photovoltaic arrays, all while starting from a molecule familiar to many chemical teams.
In my own experience, switching from more common pyridine derivatives to this compound simplified purification and increased the scope of late-stage functionalization. I’ve seen projects hit a wall with standard 2-bromopyridines: reactions stall, purification drags on, overall yield drops, or the team burns cycles on plan B. Moving to a structurally richer, more accommodating motif like Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate helped keep timelines manageable.
Colleagues running parallel syntheses have also noted improved NMR clarity and easier mass spec confirmation with this core, a side effect of both the rigid backbone and consistent fragmentation. These little advantages accumulate — fewer hours spent puzzling over spectral ambiguities means more time optimising real structure–activity trends.
Every chemist eventually faces the reality of budget constraints. While the cost per gram can run higher than for generic pyridines, the time and resource savings in downstream chemistry often make up the difference. Working with a stable, pure, and modular building block limits the need for intermediate purification and reduces cycle time, two expenses that usually dwarf the sticker price of a reagent.
Quality sourcing is a practical concern. Not all vendors supply material with high, batch-to-batch consistency and sufficient documentation. False savings from questionable suppliers can lead to batch failures and regulatory headaches, especially if the compound ends up in a preclinical submission. Sticking with established, reliable providers who back up their claims with analytical data and purity checks saves stress later — and makes audits and regulatory checks much smoother down the line.
Safety-wise, this molecule behaves predictably under standard laboratory precautions. Avoiding excessive heat and direct inhalation is standard practice for compounds of this family. Acquainting new researchers with hazard profiles and ensuring access to material safety data is an important step; reinforced training limits incidents and preserves project momentum.
Pharmaceutical discovery today prizes flexibility, responsiveness, and the ability to quickly pivot as new insights emerge. Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate fits right into that workflow: a tool for building parallel libraries, troubleshooting bottlenecks, and delivering candidates tuned for activity, toxicity profile, and pharmacokinetics. The ready points for molecular modification — ester hydrolysis, nucleophilic substitution at the bromo group, or cross-coupling at various positions — mean chemists are rarely forced to retrace steps or settle for suboptimal analogs just to fit the template of a more rigid starting material.
These traits support agile project strategies, reduce synthetic redundancy, and encourage medicinal chemists to push for more creative, ambitious scaffolds. Perhaps more importantly, compounds like this one encourage an iterative mindset: a route blocked by a failed coupling isn’t the end, but a reminder to pivot and refine, using the same building block in a slightly different way. This resilience under pressure keeps research robust even in lean budget cycles or accelerated development sprints.
In a world where research dollars stretch thinner each year and peer-reviewed results count more than ever, choosing the right tools is both a science and an art. Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate stands out because it delivers value far beyond its chemical formula. Reliable behavior, modular reactivity, and compatibility with modern synthetic strategies mean it makes a mark in the hands of innovators, whether they’re working at the bench or analyzing supply chains. If you care about staying competitive and agile in the face of evolving scientific demands, this is a molecule that deserves a place on your shelf.
Chemistry evolves fast, but the need for rock-solid starting materials never fades. Ethyl 6-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate has earned its reputation as an ally to research teams who measure success not just in molecules made, but in problems solved. Newer synthesis techniques, smarter automation, and data-driven design all benefit from building blocks that keep up — and don’t limit your ability to dream bigger with each experiment.
In the years ahead, demand is only likely to grow for adaptable pyridine scaffolds with broad applicability and clean, reproducible performance. This molecule, already developed with an eye toward both reactivity and handling ease, points the way forward for chemical manufacturing and inventive laboratory science alike. This isn’t just a stand-in for what’s been done before — it’s a real step up for those who want chemistry to work smarter, not just harder.